Insider Trading activities of Oyster Point Pharma, Inc. (OYST)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oyster Point Pharma, Inc. (OYST) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oyster Point Pharma, Inc. since year 2005. Table 2 shows the detailed insider transactions of Oyster Point Pharma, Inc. since 2005. The reporting company's ticker symbol is OYST. The reporting company's CIK number is 1720725.
The total value of stock buying since 2005 is $53,924,800.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Oyster Point Pharma, Inc. (OYST).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-11 3,370,300 $53,924,800 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Oyster Point Pharma, Inc. insiders (OYST)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-11-04 Kkr Associates Hcsg L.p. Buy 155,000 16.00 2,480,000
2019-11-04 Lochner Daniel (Chief Financial Officer) Buy 6,300 16.00 100,800
2019-11-04 Nau Jeffrey (President and CEO) Buy 1,000 16.00 16,000
2019-11-04 Snisarenko John (Chief Commercial Officer) Buy 3,000 16.00 48,000
2019-11-04 Ozawa Clare (Director) Buy 562,500 16.00 9,000,000
2019-11-04 Vida Ventures, Llc Buy 185,000 16.00 2,960,000
2019-11-04 Kkr Fund Holdings Gp Ltd Buy 155,000 16.00 2,480,000
2019-11-04 Versant Side Fund Iv, L.p. (10% Owner) Buy 590,000 16.00 9,440,000
2019-11-04 Sandell Scott D (10% Owner) Buy 935,000 16.00 14,960,000
2019-11-04 Link William J Phd (Director) Buy 27,500 16.00 440,000
2019-11-04 Lainovic Sacha (Director) Buy 750,000 16.00 12,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of OYST listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oyster Point Pharma, Inc. (symbol OYST, CIK number 1720725) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month